Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.Joyce O’Shaughnessy, Daniel D. Von Hoff, Gary J. Kelloff et al.|PubMed|2002Cited by 383
First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid TumorsCristiana Sessa, Udai Banerji, Karen S. Jacks et al.|Clinical Cancer Research|2013Cited by 160